MARKETSBiogen Shares Rise After ‘Best-Case’ Alzheimer’s Drug Trial ResultsadminSeptember 28, 2022September 28, 2022 September 28, 2022September 28, 2022 On Wednesday, shares of Biogen (NASDAQ:BIIB) are trading sharply higher in pre-market as the company has announced positive topline results for its experimental Alzheimer’s drug....